Epigenetic patterns of the retinoic acid receptor β2 promoter in retinoic acid-resistant thyroid cancer cells

[1]  司履生.  Cancer epigenetics , 2006 .

[2]  C. Rochette-Egly.  Dynamic Combinatorial Networks in Nuclear Receptor-mediated Transcription* , 2005, Journal of Biological Chemistry.

[3]  R. Niles.  Signaling pathways in retinoid chemoprevention and treatment of cancer. , 2004, Mutation research.

[4]  J. Larghero,et al.  1 alpha,25-dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells. , 2004, Molecular endocrinology.

[5]  S. Lippman,et al.  Hypermethylation of the Retinoic Acid Receptor-β2 Gene in Head and Neck Carcinogenesis , 2004, Clinical Cancer Research.

[6]  J. Issa,et al.  Methylation and Regulation of Expression of Different Retinoic Acid Receptor Beta Isoforms in Human Colon Cancer , 2004, Cancer biology & therapy.

[7]  M. Flexor,et al.  Activation of Retinoic Acid Receptor-dependent Transcription by All-trans-retinoic Acid Metabolites and Isomers* , 2002, The Journal of Biological Chemistry.

[8]  Arvind Virmani,et al.  Loss of retinoic acid receptor beta gene expression is linked to aberrant histone H3 acetylation in lung cancer cell lines. , 2002, Cancer research.

[9]  H. Müller-Gärtner,et al.  Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  J. Minna,et al.  Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. , 2001, Journal of the National Cancer Institute.

[11]  R. Lauro,et al.  Pax8 has a key role in thyroid cell differentiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Widschwendter,et al.  Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. , 2000, Journal of the National Cancer Institute.

[13]  J. Köhrle,et al.  Retinoic acid redifferentiation therapy for thyroid cancer. , 2000, Thyroid : official journal of the American Thyroid Association.

[14]  M. Vidaud,et al.  Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR , 2000, Leukemia.

[15]  S. Filetti,et al.  Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. , 1999, European journal of endocrinology.

[16]  P. Chambon,et al.  Physical and Functional Interactions between Cellular Retinoic Acid Binding Protein II and the Retinoic Acid-Dependent Nuclear Complex , 1999, Molecular and Cellular Biology.

[17]  V. Lazar,et al.  Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. , 1999, The Journal of clinical endocrinology and metabolism.

[18]  C. Daumas-Duport,et al.  Retinoic acid modulates RAR alpha and RAR beta receptors in human glioma cell lines. , 1999, Anticancer research.

[19]  I. Fleming,et al.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.

[20]  R. Fimmers,et al.  Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  D. Sinnett,et al.  Demethylation by 5-aza-2´-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor ß gene in human colon carcinoma cells , 1998, Anti-cancer drugs.

[22]  P. Rochaix,et al.  Reduced expression of retinoic acid receptor beta protein (RARβ) in human papillary thyroid carcinoma: immunohistochemical and Western blot study , 1998, Histopathology.

[23]  J. Köhrle,et al.  Functional retinoid and thyroid hormone receptors in human thyroid‐carcinoma cell lines and tissues , 1998, International journal of cancer.

[24]  J. Köhrle,et al.  Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells. , 1997, Biochemical and biophysical research communications.

[25]  B. Shroot,et al.  Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimers , 1997, Oncogene.

[26]  K. Ain,et al.  Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. , 1995, The Journal of clinical endocrinology and metabolism.

[27]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[28]  J. Köhrle,et al.  Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines. , 1994, The Journal of clinical endocrinology and metabolism.

[29]  H. de Thé,et al.  All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. , 1991, The Journal of clinical investigation.

[30]  H. Stunnenberg,et al.  Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene , 1990, Nature.

[31]  P. Laird.  Cancer epigenetics , 2005 .

[32]  R. Lotan,et al.  Retinoids and their receptors in cancer development and chemoprevention. , 2002, Critical reviews in oncology/hematology.

[33]  G. D. Vita,et al.  Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[34]  H. de Thé.  Altered retinoic acid receptors. , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  A. Dejean,et al.  The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. , 1994, Oncogene.

[36]  D. Wynford‐Thomas.  In vitro models of thyroid cancer. , 1993, Cancer surveys.

[37]  A. Frilling,et al.  Growth regulation of normal thyroids and thyroid tumors in man. , 1990, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.